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Proximal tubule cells stimulated by lipopolysaccharide
inhibit macrophage activation
YIPING WANG, YUET-CHING TAY, and DAVID C.H. HARRIS
Center for Transplantation and Renal Research, The University of Sydney at Westmead Millenium Institute,
Westmead, Sydney, Australia
Proximal tubule cells stimulated by lipopolysaccharide inhibit
macrophage activation.
Background. Tubule cells can produce a variety of cy-
tokines, extracellular matrix (ECM) components, and adhesion
molecules in vitro and in vivo. It is generally assumed that stim-
ulated tubule cells are proinflammatory and at least partially
responsible for interstitial inflammation. However, the overall
effect of tubular cells on interstitial cells is unknown. In this
study, pro- and anti-inflammatory cytokine production and net
effects on macrophages of tubule cells activated by lipopolysac-
charide (LPS) were examined.
Methods. Tubule cells stimulated with LPS expressed tumor
necrosis factor-a (TNF-a), interleukin (IL)-1b , IL-12, mono-
cyte chemoattractant protein-1 (MCP-1), IL-10, and trans-
forming growth factor-b (TGF-b). Conditioned media were
collected from confluent monolayers of rat tubule cells stim-
ulated, or not, by LPS for 4 and 18 hours, respectively.
Macrophages were cultured with conditioned media and/or LPS
(0.5 lg/mL) for 18 hours.
Results. TNF-a and IL-lb mRNA of macrophages stimulated
by LPS increased more than fivefold when cultured with control
conditioned media from unstimulated tubule cells. Surprisingly,
TNF-a and IL-lb levels of macrophages stimulated by LPS were
not increased when cultured with conditioned media from acti-
vated tubule cells. Neutralizing antibodies to IL-10 and TGF-b
were used to define the inhibitory component(s) in conditioned
medium. Anti-IL-10, but not anti-TGF-b , abolished partially
the inhibitory effects of conditioned media on macrophages.
Conclusion. Tubule cells produce both pro- and anti-
inflammatory cytokines and the net effect, partially explained
by IL-10, of tubule cells activated with LPS is to inhibit activity
of macrophages. Thus, the net effect of activated tubule cells
on interstitial pathology may in certain circumstances, be anti-
rather than pro-inflammatory.
In chronic renal diseases, the severity of tubulointer-
stitial damage correlates well with impairment of renal
function and prognosis. The mechanisms underlying
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tubulointerstitial injury in chronic renal diseases are not
clear, but include interstitial infiltration of macrophages
and other cells. Depletion of macrophages has been
shown to reduce renal injury in various models of
glomerulonephritis [1–3], suggesting that macrophages
play an important role in progression of chronic re-
nal diseases. The damaging effects of macrophages in-
volve interactions with intrinsic renal cells; for example,
macrophages have been shown to alter the phenotype of
tubule cells via the release of soluble mediators or cell to
cell surface contact [4].
In response to various stimuli such as lipopolysac-
charide (LPS), cytokines, urinary proteins, and hypoxia,
tubule cells are capable of producing a large range of
mediators, including chemoattractants, cytokines, and
matrix proteins [5, 6]. It is generally believed that sol-
uble mediators released from tubule cells worsen inter-
stitial disease by recruiting and activating inflammatory
cells such as macrophages or lymphocytes [7]. However,
there is no direct proof of this hypothesis. Tubule cells
produce a redundant network of mediators, including
both proinflammatory and anti-inflammatory cytokines.
Thus, the net effect of pro- and anti-inflammatory sig-
nals from tubule cells could be to either worsen or limit
interstitial inflammation. The effects of single mediators
released from tubule cells, including interleukin (IL)-1,
tumor necrosis factor-a (TNF-a), monocyte chemoat-
tractant protein-1 (MCP-1), and regulated upon activa-
tion, normal T-cell expressed and secreted (RANTES),
have been studied intensively [8, 9], yet the overall effects
of activated tubule cells on inflammatory cells has been
studied less. This study explored the net paracrine effects
on macrophages of tubule cells activated by LPS.
METHODS
Animals
Inbred male Wistar rats (250 to 300 g) were supplied
by the Animal Care Facility, Westmead Hospital, Sydney,
Australia.
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Cells and cell culture
For primary culture, tubule cells were isolated and
cultured from normal male Wistar rats using isopycnic
centrifugation. Cells were grown in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with epidermal
growth factor (EGF) (10 ng/mL) and insulin (5 mg/mL) in
a 5% CO2/95% O2 environment[10]. Experiments were
commenced after cells had reached confluence, which was
usually between 4 to 5 days after the isolation procedure.
The cultured tubule cells were 95% to 99% proximal
tubule cells, with the remainder being distal tubule cells.
A rat macrophage cell line (CRL-2192) [American Type
Culture Collection (ATCC), Manassas, VA, USA] was
propagated in F-12K medium with 2 mmol/L L-glutamine
and supplemented with 15% fetal calf serum (FCS) in a
5% CO2 and 95% O2 air atmosphere. Tubule cells were
stimulated with LPS (2.5 lg/mL) for 18 hours and their
cytokine expression examined. Rat cytokines (TNF-a,
IL-1b , MCP-1, and IL-10) were obtained from Endo-
gen (Cambridge, MA, USA), and antibodies [anti-IL-
10 and anti-transforming growth factor-b (TGF-b)] were
obtained from A&D System (Oxon, UK).
Insert culture
To examine polarized secretion from tubule cells, bi-
layer insert culture was used. Confluent cells in primary
culture were detached with trypsin treatment and washed
with 10% FCS medium. Four hundred microliters of cells
(5 × 104/mL) were transferred to 12 mm inserts (0.4 lm
pore diameter) (Millipore-CM, Bedford, MA, USA) pre-
viously coated with rat tail collagen. These inserts allow
tubule cells to grow on a permeable membrane and se-
crete cytokines into apical and basolateral compartments.
After 24 to 36 hours of incubation, cells were confluent
on the insert membrane. The permeability of confluent
monolayer was assessed by adding albumin I125 at 0.2 lCi/
mL. Approximately 5% leakage was detected during
24 hours of incubation. LPS (2.5 lg/mL) was added onto
inserts (apical surface) or into wells (basolateral surface)
and incubated for 8 hours. Aliquots of 100 lL were re-
moved from both apical and basolateral sides for enzyme-
linked immunosorbent assay (ELISA).
Preparation of conditional media
Confluent tubule cells in 100 mm culture plates were
washed twice with DMEM-F12 Ham without any supple-
ments and then incubated in 4 mL of DMEM-F12 Ham
alone or 4 mL of DMEM-F12 Ham containing 2.5 lg/mL
LPS for 4 and 18 hours at 37◦C. At the end of 4 or18 hours,
the media were removed, washed twice with DMEM-F12
Ham, replaced with 4 mL DMEM-F12 Ham with 2% FCS,
and incubated for a further 24 hours. Media were then col-
lected, filtered through a 0.2 lm filter and stored at −80◦C
until use. The amount of residual LPS in conditioned me-
dia was equivalent to that of standard commercial media
(<0.001 EU), and insufficient to stimulate macrophages.
Media conditioned by tubule cells in the absence of LPS
served as control-conditioned media. Media conditioned
by tubule cells in the presence of LPS were designated as
conditioned media.
Dose-dependent and time-dependent
stimulation of macrophage cytokines
Macrophages grown in culture plates were harvested
on the day of treatment and seeded onto 35 mm culture
plates (5 to 10 × 105 cells/plate). LPS (0 to 2.0 lg/mL) was
added to the plates, and after 18 hours incubation at 37◦C,
the cells were harvested for RNA extraction. To follow
the time course of cytokine expression in macrophages in
response to LPS stimulation, the cells were harvested at 6,
12, and 24 hours after addition of LPS (0.5 lg/mL). Cells
grown without LPS were harvested after 24 hours and
used as unstimulated control. The combined effects of
LPS (0.5 lg/mL) were examined with TNF-a (10 ng/mL),
IL-1b (10 ng/mL), MCP-1 (100 ng/mL), and IL-10
(10 ng/mL).
Effect of tubule cells–derived conditioned
media on cytokine expression in macrophages
To examine whether tubule cells have the ability to pro-
duce modulators of macrophage function, macrophages
in F-12K macrophage growth medium were seeded onto
35 mm culture plates (5 to 10 × 105 cells/plate). Con-
ditioned control media (from unstimulated tubule cells)
and conditioned media (from LPS-stimulated tubule
cells) were diluted serially from 2 to 40 times and added
to the culture plates. The plates were incubated at 37◦C
for 6 hours. After 6 hours, LPS (0.5 lg/mL) was added
and the plates were incubated for a further 18 hours.
LPS was omitted from some plates to serve as a neg-
ative control for unstimulated macrophages. The cells
were harvested for RNA extraction. In some experiments
macrophages were pretreated with diluted (1:2) condi-
tioned media to which anti-IL-10 antibody (tested at 0.5,
1.0, and 2.5 lg/mL) had been added, and diluted (1:2)
conditioned media to which anti-TGF-b had been added.
Normal IgG, in amounts equivalent to those of the anti-
bodies, was added to control plates.
Semiquantitative reverse transcription-polymerase
chain reaction (RT-PCR)
Total RNA was isolated using RNAzol B (Teltest,
Frienswood, TX, USA). Transcription of mRNA in
tubule cells or macrophages was determined using semi-
quantitative RT-PCR. The design of primers and condi-
tions for RT-PCR have been described previously [11, 12].
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Fig. 1. Expression of pro-inflammatory (A) and anti-inflammatory (B)
cytokines relative to 18 S by reverse transcription-polymerase chain re-
action (RT-PCR) in tubule cells exposed to lipopolysaccharide (LPS)
(2.5 lg/mL). Expression of proinflammatory cytokines interleukin (IL)-
1b , tumor necrosis factor-a (TNF-a), IL-12, and monocyte chemoat-
tractant protein-1 (MCP-1) and anti-inflammatory cytokines IL-10 and
transforming growth factor-b (TGF-b) mRNA were significantly in-
creased in tubule cells exposed to LPS. However, IL-4 and IL-13 were
undetectable. The results are from five separate experiments and each
performed in triplicate. Data are mean ± SD.
PCR product was loaded into a 1.2% agarose gel stained
by ethidium bromide (0.5 lg/mL). The gel was viewed and
scanned using a Fluo-S MultiImager system from Bio-
Rad (Hercules, CA, USA) (170 to 7700). The expression
of all cytokines of interest was normalized against 18S
expression (Internal Standards, Ambion Inc., Austin TX,
USA).
ELISA
TNFa, IL-1b , and IL-10 in conditioned media and the
media from apical and basolateral sides of insert culture
were assessed by ELISA. The procedures were under-
taken according to manufacturer’s protocol for individ-
ual ELISA kits (BioSource International, Inc., Camarillo,
CA USA).
Statistics
The results are expressed as the mean ± SD, and sta-
tistical significance of differences within the groups and
among groups was determined by one way analysis of
variance (ANOVA). The post-test of ANOVA was the
post hoc least significant difference (LSD) test (SPSS,
Chicago, IL, USA). A value less than 0.05 was consid-
ered to be significant.
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Fig. 2. Concentration of interleukin (IL)-10, IL-1b and tumor necro-
sis factor-a (TNF-a) protein in conditioned media. IL-10, IL-1b , and
TNF-a were examined by enzyme-linked immunosorbent assay
(ELISA) in conditioned media from unstimulated tubule cells and
tubule cells exposed to lipopolysaccharide (LPS) (2.5 lg/mL). Data
are mean ± SD.
RESULTS
Induction of cytokines in tubule cells
By semiquantitative RT-PCR, the proinflammatory
cytokines-IL-1b , TNF-a, IL-12, and MCP-1, and anti-
inflammatory cytokines-IL-4, IL-10, TGF-b , and IL-13
were examined in tubule cells stimulated with LPS
(2.5 lg/mL) for 18 hours. mRNA of proinflammatory
cytokines IL-1b , TNF-a, IL-12, and MCP-1 and anti-
inflammatory cytokines IL-10 and TGF-b were increased
in tubule cells stimulated with LPS, but IL-4 and IL-13
mRNA was not detected in tubule cells either with or
without LPS stimulation (Fig. 1). As a positive control,
IL-4 and IL-13 mRNA were detected in spleen and renal
cortex of rats with adriamycin nephropathy at week 4.
mRNA of both proinflammatory cytokines-IL-1b , TNF-
a, IL-12, and MCP-1 and anti-inflammatory cytokines
IL-10 and TGF-b increased with a similar time frame in
tubule cells stimulated with LPS, each starting to increase
after 2 hours, reaching a peak at 6 to 12 hours and lasting
for at least 24 hours.
To examine whether the induced transcripts of cy-
tokines were translated to proteins and secreted into
medium, we assessed IL-1b , TNF-a, and IL-10 protein
levels in conditioned media, after tubule cells were stim-
ulated with LPS. IL-10 and TNF-a increased dramatically,
about four- to sevenfold, whereas the increase in IL-1b
was less marked, about one- to twofold (Fig. 2).
If cytokines are to act as mediators in interaction be-
tween tubule cells and interstitial cells, then tubule cells
should secrete cytokines across their basolateral surface
toward the interstitial space. To explore this important is-
sue, polarized secretion from tubule cells was examined.
Tubule cells stimulated by LPS from either the apical or
basolateral side secreted IL-1b , TNF-a and IL-10. The
concentration of TNF-a and IL-10 proteins was greater
in basolateral than in apical media, whereas IL-1b was
the same in media of the two sides (Fig. 3). Moreover,
apical stimulation of tubule cells with LPS resulted in a
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Fig. 3. Polarized secretion of tumor necrosis factor-a (TNF-a), interleukin (IL)-1b, and IL-10 from tubule cells. The total amount of TNF-a (A and
B), IL-1b (C and D), and IL-10 (E and F) secreted into apical and basolateral media were examined after apical lipopolysaccharide (LPS) stimulation
(A, C, and E) and basolateral stimulation (B, D, and F). Both apical and basolateral secretion of IL-10 and TNF-a were greater following apical
LPS stimulation versus basolateral stimulation. Basolateral secretion was greater than apical secretion with either apical or basolateral stimulation.
However, apical and basolateral secretion of IL-1b were no different, nor was there a differential effect of apical versus basolateral stimulation.
Data are mean ± SD.
greater release of TNF-a and IL-10 both apically and ba-
solaterally, than did basolateral stimulation with LPS.
Effects of conditioned media on
cytokine expression of macrophages
The kinetics of expression of TNF-a and IL-1b were
examined in macrophages. Unstimulated macrophages
expressed TNF-a and IL-1b weakly. Following exposure
to LPS from 0.1 to 2 lg/mL for 18 hours, macrophages
produced TNF-a in a dose-dependent manner (Fig. 4).
After 2 hours of LPS (0.5 lg/mL) stimulation, an in-
crease in expression of TNF-a was detectable at 3 hours,
reached a peak at 6 hours, and was sustained for at least
24 hours (Fig. 5). Macrophages expressed IL-1b mRNA
in a dose-dependent and time-dependent manner sim-
ilar to TNF-a, except there was less increase in IL-1b
mRNA (fourfold) than TNF-a (sevenfold) in response
to LPS (0.5 lg/mL), indicating TNF-a is a more sen-
sitive marker of activated macrophages (Figs. 5 and 6).
Therefore, TNF-a was used as a marker for macrophage
activation in most of the following experiments. LPS
(0.5 lg/mL) was chosen to activate macrophages in fur-
ther experiments, as this dose activated macrophages
moderately, permitting assessment of both inhibition and
stimulation of macrophage TNF-a and IL-1b production.
The effect of LPS (0.5 lg/mL) was augmented (TNF-a,
IL-1b , and MCP-1) or inhibited (IL-10) by addition of
recombinant cytokines (Fig. 7).
Macrophages without any LPS stimulation were cul-
tured in conditioned media. mRNA expression of
TNF-a and IL-1b of macrophages was not significantly
different whether grown in media obtained from tubule
cells stimulated with LPS or from unstimulated tubule
cells. However, mRNA expression of TNF-a and IL-1b
of macrophages stimulated with LPS (0.5 lg/mL) was re-
duced significantly by media from tubule cells stimulated
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Fig. 4. Dose-dependent effect of lipopolysaccharide (LPS) on tu-
mor necrosis factor-a (TNF-a) mRNA expression in macrophages.
Macrophages were stimulated with increasing concentrations of LPS
(0.1 to 2 lg/mL). The results are from five separate experiments and
each performed in triplicate. Data are mean ± SD.
0
1
2
3
4
TN
F 
α
/1
8s
0 6 12 18 24
Time, hours
LPS ( 1 µg/mL)
LPS ( 0.5 µg/mL)
LPS ( 0.1 µg/mL)
Fig. 5. Time-dependent effect of lipopolysaccharide (LPS) on tumor
necrosis factor-a (TNF-a) mRNA expression in macrophages. TNF-
a mRNA expression reached its peak in approximately 6 hours and
was sustained for at least 24 hours with LPS. The results are from five
separate experiments and each performed in triplicate. Data are mean
± SD.
for 18 hours with LPS (Fig. 6). Similarly, an inhibitory
effect on macrophages was also shown with the media
from tubule cells stimulated with LPS from an early time
point of stimulation (4 hours). This inhibitory effect of
conditioned media was concentration-dependent (Fig. 8).
Moreover, the inhibitory effect of conditioned media
was also exhibited in macrophages activated with TNF-a
(Fig. 9).
Identification of the active inhibitor
in tubule cell–conditioned media
To define the inhibitors in conditioned media, the ef-
fects of inhibiting inflammatory cytokines were examined
using neutralizing antibodies. Anti-IL-10 specific anti-
body abolished partially the inhibitory effect of condi-
tioned media from activated tubule cells. Expression of
TNF-a of macrophages in conditioned media increased
by 40% with anti-IL-10 (Fig. 10). The inhibitory effect
was not increased by higher doses of anti-IL-10. How-
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Fig. 6. The effect of tubule cell–conditioned media on tumor necro-
sis factor-a (TNF-a) and interleukin (IL)-1b mRNA expression of
macrophages activated by lipopolysaccharide (LPS) (0.5 lg/mL).
TNF-a mRNA expression (A) and IL-1b mRNA expression (B) of
macrophages were increased in control conditioned media (CCM), but
increased TNF-a and IL-1b expression were inhibited in conditioned
media (CM) from tubule cells exposed to LPS for 18 hours. Very sim-
ilar results were obtained with conditioned media exposed to LPS for
4 hours. The results are from five separate experiments and each per-
formed in triplicate. Data are mean ± SD.
ever, anti-TGF-b had no effect on the inhibitory effect
of conditioned media (Fig. 10). The combination of both
antibodies had a similar effect on TNF-a expression of
macrophages to that of anti-IL-10 alone.
DISCUSSION
To examine the influence of stimulated tubule cells on
macrophages, we assessed cytokine production by tubule
cells and the net effect of conditioned media from tubule
cells on macrophages. Tubule cells produced both proin-
flammatory cytokines IL-1b , TNF-a, IL-12, and MCP-1
and anti-inflammatory cytokines IL-10 and TGF-b . Both
proinflammatory and anti-inflammatory cytokines were
secreted by tubule cells across their apical or baso-
lateral membranes, but preferentially across their ba-
solateral surface. Surprisingly, conditioned media from
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Fig. 7. Combined effects of recombinant cytokines [tumor necro-
sis factor-a (TNF-a), interleukin (IL)-1b, monocyte chemoattractant
protein-1 (MCP-1) and IL-10] and lipopolysaccharide (LPS). TNF-a,
IL-1b , or MCP-1 increased macrophage TNF-a mRNA expression (A),
and TNF-a and MCP-1 increased macrophage IL-1b mRNA expression
(B). Recombinant IL-10 inhibited both TNF-a, and IL-1b expression.
The results are from three separate experiments and each performed
in triplicate. Data are mean ± SD.
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Fig. 8. The effect of tubule cell–conditioned media (CM) in different
concentrations on tumor necrosis factor-a (TNF-a) mRNA expression
of macrophages. The inhibitory effect of conditioned media in dilutions
from 1:2 to 1:40 was dose-dependent. The results are from three separate
experiments and each performed in triplicate. Data are mean ± SD.
Abbreviations are: LPS, lipopolysaccharide; CCM, control conditioned
media.
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Fig. 9. The effect of tubule cell–conditioned media (CM) on tumor
necrosis factor-a (TNF-a) mRNA expression of macrophages activated
by TNF-a. TNF-a mRNA expression of macrophages was increased in
control conditioned media (CCM), but increased TNF-a expression was
inhibited in conditioned media from tubule cells exposed to lipopolysac-
charide (LPS). The results are from three separate experiments and
each performed in triplicate. Data are mean ± SD.
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Fig. 10. Effect of neutralizing antibodies against interleukin (IL)-10
and transforming growth factor-b (TGF-b) on tumor necrosis factor-a
(TNF-a) mRNA expression of stimulated macrophages in response to
tubule cell–conditioned media (CM). Anti- IL-10 partially abolished the
inhibitory effect in conditioned media. However, there was no effect of
anti-TGF-b on the inhibitory effect of conditioned media. The results
are from three separate experiments and each performed in triplicate.
Data are mean ± SD.
activated tubule cells suppressed TNF-a and IL-1b
mRNA expression of macrophages. To define the in-
hibitory components involved, the effects of IL-10 and
TGF-b were examined with neutralizing antibodies.
Anti-IL-10, but not anti-TGF-b , partially abolished the
inhibitory effects of conditioned media on macrophages.
Renal interstitial inflammation is an integral patho-
logic component of chronic proteinuric renal disease, and
its presence predicts the progression and prognosis of
chronic renal disease [13]. Tubule cells play an important
role in development and evolution of interstitial inflam-
mation, due in part to the elaboration of a network of pro-
and anti-inflammatory cytokines. Tubule cell cytokines
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are of overriding importance in the interaction between
tubule cells and the interstitium, but act in concert with
other factors, including adhesion molecules, complement,
and major histocompatibility complex (MHC). It has
been established that expression of a number of indi-
vidual proinflammatory cytokines such as TNF-a, IL-1b
MCP-1, and RANTES are increased in tubule cells in var-
ious renal diseases, suggesting that tubular cell cytokines
could contribute to the development and progression of
interstitial inflammation [14]. Experiments in vitro have
also showed that the expression of those cytokines was
increased by stimulated tubule cells in response to var-
ious phenomena such as proteinuria, hypoxia, and en-
dotoxin, indicating that stimulated tubule cells could be
a major source of cytokines involved in pathogenesis of
chronic renal diseases [15]. However, the true role of var-
ious tubule cell cytokines in modulating interstitial in-
flammation is unclear, as administration or inhibition of
individual cytokines is ineffective or only partially effec-
tive in influencing the inflammatory process. This lack of
efficacy could be due to a complex network of tubule cell
cytokines with overlapping or opposing effects on inter-
stitial target cells. To determine the importance of the bal-
ance between pro- and anti-inflammatory cytokines, we
surveyed the profile of tubule cell cytokines, and found
increased mRNA expression of both proinflammatory
cytokines (IL-1b , TNF-a, IL-12, and MCP-1) and anti-
inflammatory cytokines (IL-10 and TGF-b). Correspond-
ingly, increased protein levels of IL-1b , TNF-a and IL-10
were also detected in media cultured from tubule cells
after stimulation by LPS. Furthermore, tubule cell secre-
tion of TNF-a and IL-10, but not IL-1b , was polarized
across the basolateral membrane, consistent with their
proposed modulatory effect on the renal interstitium in
vivo.
Tubule cells are widely considered to be activators
of interstitial inflammation. Yet, as both pro- and anti-
inflammatory cytokines are released by tubule cells, it
is not possible to predict their net effect on interstitial
target cells. To assess the true proinflammatory potential
of tubular cells, it was necessary to observe the net effect
of conditioned media harvested from tubule cells on an
interstitial target. Against expectations, the net signal of
conditioned media from stimulated tubule cells on TNF-a
and IL-1b production by activated macrophages was in-
hibitory. The relative importance of potential inhibitory
components of conditioned media was defined by neu-
tralizing antibodies against IL-10 and TGF-b . The data
demonstrated that IL-10, but not TGF-b was partially re-
sponsible for the inhibitory effects of conditioned media.
Increased IL-10 expression has been demonstrated in var-
ious glomerulonephritides, and interferon-c (INF-c)/IL-
10 ratio has been shown to correlate with the severity of
renal diseases such as IgA nephropathy [16, 17]. In vitro,
IL-10 has been defined as a deactivator of macrophages
by its inhibition of generation of macrophage prod-
ucts such as IL-1b , TNF-a, reactive oxygen species,
and matrix metalloproteinases [18]. IL-10 also inhibits
the differentiation of monocytes into macrophages
and promotes apoptosis of macrophages in concert
with granulocyte-macrophage-colony-stimulating factor
(GM-CSF) [19]. In vivo, IL-10 has been reported to atten-
uate macrophage-induced glomerular injury [20]. How-
ever, others have reported an inability of IL-10 to pre-
vent renal injury in anti-glomerular basement membrane
(GBM) glomerulonephritis, possibly due to its failure to
inhibit macrophages in this situation [21]. The pathophys-
iologic significance of IL-10 produced by tubule cells in
vivo is uncertain and likely to be contextural, and de-
pendent on the nature and phase of the specific renal
disease. For example, IL-10 could act as a deactivator of
macrophages and also serve as a cofactor for promot-
ing the growth of T cells, B cells, and mast cells and
up-regulating the cytolytic activity of natural killer (NK)
cells [22]. Moreover, it has been shown that IL-10 medi-
ates mesangial cell proliferation and induces expression
of E-selectin on endothelial cells, an effect crucial to the
accumulation of neutrophils at the site of inflammation
[23, 24].
Although the expression of TGF-b by tubule cells was
increased in response to LPS, TGF-b was not one of the
inhibitory components of the conditioned media in this in
vitro experiment. However, an anti-inflammatory role for
TGF-b produced by tubule cells is not excluded in vivo,
as TGF-b is secreted in an inactive form and requires
enzymatic activation involving the participation of other
cells [22]. In vivo, TGF-b converted to its active moiety
in extracellular space could stimulate proliferation and
matrix production of fibroblasts and mesangial cells, re-
spectively, leading to interstitial and glomerular sclerosis
[26].
In present study, anti-IL-10 did not completely block
the inhibitory effect of conditioned media on TNF-a pro-
duction by activated macrophages. One possible reason
for this could be related to effects of inhibitory autocrine
loop of macrophages. Function of macrophages stimu-
lated by LPS was shown to be controlled by stimulatory
autocrine loops involving IL-12 and inhibitory autocrine
loops involving IL-10 [27]. Anti-IL-10 not only neutral-
ized IL-10 in conditioned media, but also blocked the IL-
10–dependent inhibitory autocrine loop of macrophages,
resulting in increase of TNF-a [28]. Another possible rea-
son for the partial blocking effect of anti-IL-10 could be
that IL-10 is not the only inhibitory component in condi-
tioned media. There are several other potential inhibitory
components, including IL-1 receptor antagonist, insulin-
like growth factor-1, macrophage inhibitory factor, and
leukemia inhibitory factor. Further studies are necessary
to determine whether and to what extent other inhibitory
factors are involved.
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LPS was chosen as the stimulator of tubule cells in
these experiments as it is an important pathogenic factor
in both acute and chronic renal disease. Other poten-
tial stimulators of tubule cells such as cytokines TNF-a
and IL-1b , proteinuria, and hypoxia also have important
roles in the development and progression of interstitial
inflammation; however, none of the these factors indi-
vidually was able to stimulate tubule cells sufficiently to
produce detectable cytokines under these experimental
conditions. Various combinations of those factors might
be able to stimulate tubule cells, and it is possible that
certain combinations could produce unique macrophage
responses to tubule cell conditioned media.
CONCLUSION
Tubule cells produce both pro- and anti-inflammatory
cytokines. In vivo these cytokines are likely to gain ac-
cess to interstitium across tubule cell basolateral mem-
brane, allowing their participation in pathophysiologic
processes underlying interstitial inflammation and fibro-
sis. Surprisingly, the net effect of media from tubule cells
activated with LPS was to inhibit activity of macrophages,
an inhibitory effect partially dependent on IL-10. These
results emphasize that the overall role of tubule cells in
progressive chronic renal disease is likely to be complex
and contextual, and may in some circumstances be to pro-
tect against interstitial injury.
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